AMPH
Amphastar Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website amphastar.com
- Employees(FY) 1615
- ISIN US03209R1032
Performance
-7.59%
1W
-13.28%
1M
-5.77%
3M
+1.4%
6M
-28.71%
YTD
-22.09%
1Y
Profile
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API). It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation; and Vasopressin to increase blood pressure in adults with vasodilatory shock. Further, the company distributes recombinant human insulin APIs and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Technical Analysis of AMPH 2024-11-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-13 16:05
- 2024-11-13 03:05
- 2024-11-12 19:00
AMPH: Lowering target price to $50.00(Argus Research)
- 2024-11-08 05:17
- 2024-11-07 13:18
Q3 2024 Amphastar Pharmaceuticals Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-11-07 02:24
- 2024-11-06 18:00
- 2024-11-06 17:35
- 2024-11-06 16:33
Amphastar: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-11-06 16:05
- 2024-11-06 03:05
- 2024-11-05 19:00
AMPH: What does Argus have to say about AMPH?(Argus Research)
- 2024-11-04 18:44
- 2024-10-31 10:01
- 2024-10-30 10:01
- 2024-10-29 06:00
- 2024-10-28 18:00
- 2024-10-25 09:40
- 2024-10-18 12:10
- 2024-10-16 11:51
- 2024-10-11 12:32
- 2024-10-08 20:00
AMPH: Lowering target price to $49.00(Argus Research)
- 2024-10-03 08:42
- 2024-09-19 11:22
- 2024-09-07 01:43
- 2024-08-28 16:10
- 2024-08-28 04:10
- 2024-08-27 20:00
AMPH: Raising target price to $51.00(Argus Research)
- 2024-08-20 20:00
AMPH: Raising target price to $48.00(Argus Research)
- 2024-08-13 18:01
Page 1 of 8
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.